ARCHIVES

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

This article is from The Cancer Letter archive.

Vol. 13 No. 26 | June 26, 1987

Download PDF Visit The Full Archive

Related Articles

Flint Chop Shows That Successful Community Program Can Be Developed And Operated Without NCI Funding

January 21, 1983

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Bills Introduced On Breast Cancer Screening, DES, Cigarette Tax Hike

January 30, 1987

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974